株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心臓カテーテル:パイプライン分析

Cardiac Catheters - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 345367
出版日 ページ情報 英文 296 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.24円で換算しております。
Back to Top
心臓カテーテル:パイプライン分析 Cardiac Catheters - Medical Devices Pipeline Assessment, 2017
出版日: 2017年09月08日 ページ情報: 英文 296 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発が進められている心臓カテーテルのパイプライン製品情報について分析しており、治験と製品開発の進行状況、段階別・セグメント別・国 (地域) 別の動向、企業と製品の詳細情報、最近の製品開発および業界の動向などの情報を盛り込んでいます。

第1章 目次

第2章 イントロダクション

  • 心臓カテーテルの概要

第3章 開発中の製品

  • 心臓カテーテル - 開発段階別のパイプライン製品
  • 心臓カテーテル - セグメント別のパイプライン製品
  • 心臓カテーテル - 国 (地域) 別のパイプライン製品
  • 心臓カテーテル - 規制別のパイプライン製品
  • 心臓カテーテル - 認証時期別 (推定) のパイプライン製品
  • 心臓カテーテル - 現在進行中の治験

第4章 心臓カテーテル - 開発中のパイプライン製品:企業別

  • 心臓カテーテル企業 - 開発段階別のパイプライン製品
  • 心臓カテーテル - 開発段階別のパイプライン製品

第5章 心臓カテーテル企業と製品の概要

  • AccuTherm Systems, Inc.
  • Andain, Inc
  • AngioDynamics, Inc.
  • Balch Hill Medical Group
  • Bioheart, Inc.
  • Boston Scientific Corporation
  • Boston TransTec, LLC
  • Cardiac Output Technologies, Inc.
  • Cardiovascular Systems, Inc.
  • Cordis Corporation
  • CorNova, Inc.
  • Delft University of Technology
  • Deliverance Ltd.
  • EndoCross Ltd.
  • EP Limited
  • Hadasit Medical Research Services & Development Ltd
  • Harvard University
  • MaRVis Technologies GmbH
  • Mayo Clinic
  • Medeon Biodesign, Inc.
  • Medical Device Investments, Inc.
  • Medikit Co., Ltd.
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Neovasc Inc.
  • Nesstent Ltd.
  • NeuroInterventional Therapeutics, Inc.
  • Northwestern University
  • Perseus Biomed Ltd.
  • Pi-Cardia Ltd
  • Pryor Medical Devices, Inc.
  • QualiMed Innovative Medizinprodukte GmbH
  • Rhythm Solutions
  • Therix Medical, Inc.
  • Topspin Medical Inc.
  • TransCardiac Therapeutics, LLC
  • Universite de Montreal
  • University of California, San Francisco
  • University of Limerick
  • Volcano Corporation
  • Voyage Medical

第6章 心臓カテーテル - 最近の動向

第7章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0436EPD

GlobalData's Medical Devices sector report, "Cardiac Catheters - Medical Devices Pipeline Assessment, 2017" provides an overview of Cardiac Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 9
  • 1.2 List of Figures 12

2 Introduction 13

  • 2.1 Cardiac Catheters Overview 13

3 Products under Development 14

  • 3.1 Cardiac Catheters - Pipeline Products by Stage of Development 14
  • 3.2 Cardiac Catheters - Pipeline Products by Segment 15
  • 3.3 Cardiac Catheters - Pipeline Products by Territory 16
  • 3.4 Cardiac Catheters - Pipeline Products by Regulatory Path 17
  • 3.5 Cardiac Catheters - Pipeline Products by Estimated Approval Date 18
  • 3.6 Cardiac Catheters - Ongoing Clinical Trials 19

4 Cardiac Catheters - Pipeline Products under Development by Companies 20

  • 4.1 Cardiac Catheters Companies - Pipeline Products by Stage of Development 20
  • 4.2 Cardiac Catheters - Pipeline Products by Stage of Development 22

5 Cardiac Catheters Companies and Product Overview 24

  • 5.1 3DT Holdings, LLC Company Overview 24
    • 5.1.1 3DT Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.2 Andain, Inc Company Overview 25
    • 5.2.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.3 AngioDynamics Inc Company Overview 26
    • 5.3.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.4 Avantec Vascular Corporation Company Overview 27
    • 5.4.1 Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.5 Balch Hill Medical Group Company Overview 28
    • 5.5.1 Balch Hill Medical Group Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.6 Boston Scientific Corp Company Overview 29
    • 5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.7 Boston TransTec LLC Company Overview 30
    • 5.7.1 Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.8 Cardiac Output Technologies, Inc. Company Overview 31
    • 5.8.1 Cardiac Output Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.9 Cardiovascular Systems Inc Company Overview 32
    • 5.9.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.10 Cordis Corp Company Overview 36
    • 5.10.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.11 CorNova, Inc. Company Overview 39
    • 5.11.1 CorNova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.12 Delft University of Technology Company Overview 42
    • 5.12.1 Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.13 Deliverance Ltd. Company Overview 43
    • 5.13.1 Deliverance Ltd. Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.14 EndoCross Ltd. Company Overview 44
    • 5.14.1 EndoCross Ltd. Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.15 EP Ltd Company Overview 47
    • 5.15.1 EP Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.16 Georgia Institute of Technology Company Overview 48
    • 5.16.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.17 Hadasit Medical Research Services and Development Ltd Company Overview 50
    • 5.17.1 Hadasit Medical Research Services and Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.18 Harvard University Company Overview 51
    • 5.18.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.19 iVascular SLU Company Overview 52
    • 5.19.1 iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.20 MaRVis Technologies GmbH Company Overview 54
    • 5.20.1 MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.21 Mayo Clinic Company Overview 55
    • 5.21.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.22 Mayo Clinic US Company Overview 56
    • 5.22.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.23 Medical Device Investments, Inc. Company Overview 57
    • 5.23.1 Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.24 Medtronic plc Company Overview 59
    • 5.24.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.25 Merit Medical Systems Inc Company Overview 60
    • 5.25.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.26 MicroPort Scientific Corp Company Overview 62
    • 5.26.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.27 Neovasc Inc Company Overview 64
    • 5.27.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview 64
  • 5.28 Nesstent Ltd. Company Overview 65
    • 5.28.1 Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.29 NeuroInterventional Therapeutics, Inc. Company Overview 66
    • 5.29.1 NeuroInterventional Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.30 Nipro Corp Company Overview 68
    • 5.30.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.31 Northwestern University Company Overview 69
    • 5.31.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.32 Ohio State University Wexner Medical Center Company Overview 70
    • 5.32.1 Ohio State University Wexner Medical Center Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.33 Perseus Biomed Ltd. Company Overview 73
    • 5.33.1 Perseus Biomed Ltd. Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.34 Pi-Cardia Ltd Company Overview 74
    • 5.34.1 Pi-Cardia Ltd Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.35 QualiMed Innovative Medizinprodukte GmbH Company Overview 76
    • 5.35.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.36 Revamp Medical Ltd Company Overview 77
    • 5.36.1 Revamp Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.37 Rhythm Solutions Company Overview 80
    • 5.37.1 Rhythm Solutions Pipeline Products & Ongoing Clinical Trials Overview 80
  • 5.38 Sonix Therapeutics Company Overview 81
    • 5.38.1 Sonix Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 81
  • 5.39 Teleflex Inc Company Overview 82
    • 5.39.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 82
  • 5.40 Therix Medical, Inc. (Inactive) Company Overview 83
    • 5.40.1 Therix Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 83
  • 5.41 Topspin Medical Inc. Company Overview 84
    • 5.41.1 Topspin Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 84
  • 5.42 TransCardiac Therapeutics, LLC Company Overview 85
    • 5.42.1 TransCardiac Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 85
  • 5.43 U.S. Stem Cell Inc Company Overview 86
    • 5.43.1 U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 86
  • 5.44 University of California San Diego Company Overview 88
    • 5.44.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 88
  • 5.45 University of California San Francisco Company Overview 89
    • 5.45.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 89
  • 5.46 University of Limerick Company Overview 91
    • 5.46.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 91
  • 5.47 University of Michigan Company Overview 92
    • 5.47.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 92
  • 5.48 University of Montreal Company Overview 93
    • 5.48.1 University of Montreal Pipeline Products & Ongoing Clinical Trials Overview 93
  • 5.49 Vascular Concepts Ltd Company Overview 94
    • 5.49.1 Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
  • 5.50 Volcano Corp Company Overview 95
    • 5.50.1 Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 95
  • 5.51 Voyage Medical (Inactive) Company Overview 96
    • 5.51.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 96
  • 5.52 Weill Cornell Medical College Company Overview 97
    • 5.52.1 Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview 97

6 Cardiac Catheters- Recent Developments 98

  • 6.1 Aug 30, 2017: Medline Remains Operational Through Hurricane Harvey and Current Recovery 98
  • 6.2 Aug 29, 2017: Abbott Issues New Updates for Implanted Cardiac Devices 98
  • 6.3 Aug 28, 2017: Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant 100
  • 6.4 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 100
  • 6.5 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 103
  • 6.6 Aug 10, 2017: Neovasc Announces Results for the Second Quarter of 2017 103
  • 6.7 Aug 09, 2017: ICU Medical Announces Second Quarter 2017 Results 106

6.8 Aug 09, 2017: U.S. Stem Cell Reports Most Successful Financial Performance in the Company's History 107

  • 6.9 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker 108
  • 6.10 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results 108
  • 6.11 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million 110
  • 6.12 Aug 03, 2017: Getinge to cooperate with Brazilian authorities on local ongoing investigations 110
  • 6.13 Aug 02, 2017: Cardiovascular Systems Reports Fiscal 2017 Fourth-Quarter Financial Results 111
  • 6.14 Aug 02, 2017: Endologix Reports Second Quarter 2017 Financial Results 113
  • 6.15 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 114
  • 6.16 Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%) 114
  • 6.17 Jul 27, 2017: Stryker reports second quarter 2017 results 115
  • 6.18 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 116
  • 6.19 Jul 27, 2017: Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year 117
  • 6.20 Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020 119
  • 6.21 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 121
  • 6.22 Jul 25, 2017: Utah Medical Products Reports Financial Performance for Second Quarter 2017 122
  • 6.23 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 128
  • 6.24 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 128
  • 6.25 Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results 130
  • 6.26 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results 132
  • 6.27 Jul 17, 2017: Getinge appoints Lars Sandstrom as CFO and Member of Getinge Executive Team 134
  • 6.28 Jul 17, 2017: Getinge has replanned the remediation in Hechingen (DE) related to the Consent Decree with FDA and makes a provision of additional SEK 488 M 134
  • 6.29 Jul 17, 2017: Getinge: Interim Report January - June 2017 135
  • 6.30 Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board 135
  • 6.31 Jul 13, 2017: Kimal prepares for further expansion 136
  • 6.32 Jul 12, 2017: STENTYS: Revenues Of €1.7 Million in the Second Quarter Of 2017 136
  • 6.33 Jul 07, 2017: MPSC New COO Glendy Wang on Board 137
  • 6.34 Jun 28, 2017: Living Values, Aligning Action: Medline Amplifies Commitment to Socially Responsible Business Growth and Impact 137
  • 6.35 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 138
  • 6.36 Jun 24, 2017: Investigation by the Brazilian Administrative Council for Economic Defense comprises two Getinge entities 140
  • 6.37 Jun 22, 2017: Millar Sells Inca Pressure-Volume Loop System to the University of Colorado to Support LVAD Research 140
  • 6.38 Jun 22, 2017: Teleflex's Vascular Solutions Issues Recall of Venture Catheters 141
  • 6.39 Jun 21, 2017: Vascular Solutions Recalls Venture Catheters due to Excess Material that May Split or Separate During Use 141
  • 6.40 Jun 20, 2017: Medtronic VP and GM Sandra Lesenfants Joins Osprey Board 142
  • 6.41 Jun 20, 2017: Medtronic VP and GM Sandra Lesenfants J oins Osprey Board 142
  • 6.42 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors 143
  • 6.43 Jun 09, 2017: Chief Financial Officer leaves Vigmed 143
  • 6.44 May 30, 2017: Interim Report Vigmed Holding 1 January - 31 March 2017 143
  • 6.45 May 26, 2017: Merit Medical Announces Appointment of New Director 144
  • 6.46 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 144
  • 6.47 May 23, 2017: MicroPort Listed as Enterprises Conforming to CSR Standards for Six Consecutive Years 147
  • 6.48 May 18, 2017: Impact of Post-Intervention Fractional Flow Reserve Measurement on Acute PCI Outcomes Investigated in Large Independent Registry 148
  • 6.49 May 17, 2017: Head-to-Head Study Validates Consistent Performance of Microcatheter FFR 149
  • 6.50 May 15, 2017: Millar Grows Adoption of Clinical Pressure-Volume (PV) Loops for Medical Research with Purchase of Inca PV System by the University of Chicago Medicine 150
  • 6.51 May 12, 2017: Abbott Initiates Voluntarily Recall of NC Traveler Coronary Dilatation Catheter 151
  • 6.52 May 10, 2017: ICU Medical Announces First Quarter 2017 Results 152
  • 6.53 May 10, 2017: Neovasc Announces Results for the First Quarter of 2017 152
  • 6.54 May 04, 2017: Abiomed Announces Q4 FY 2017 Revenue of $124.7 Million, Up 33% Over Prior Year and Total Year Revenue of $445.3 Million, Up 35% Over Prior Year 155
  • 6.55 May 04, 2017: Teleflex Reports First Quarter 2017 Results 156
  • 6.56 May 04, 2017: Endologix Reports First Quarter 2017 Financial Results 157
  • 6.57 May 03, 2017: Cardiovascular Systems Reports Fiscal 2017 Third-Quarter Financial Results 158
  • 6.58 May 02, 2017: Medline Names New President of Canadian Business 160

7 Appendix 293

  • 7.1 Methodology 293
  • 7.2 About GlobalData 296
  • 7.3 Contact Us 296
  • 7.4 Disclaimer 296

List of Tables

1.1 List of Tables

  • Table 1: Cardiac Catheters - Pipeline Products by Stage of Development 14
  • Table 2: Cardiac Catheters - Pipeline Products by Segment 15
  • Table 3: Cardiac Catheters - Pipeline Products by Territory 16
  • Table 4: Cardiac Catheters - Pipeline Products by Regulatory Path 17
  • Table 5: Cardiac Catheters - Pipeline Products by Estimated Approval Date 18
  • Table 6: Cardiac Catheters - Ongoing Clinical Trials 19
  • Table 7: Cardiac Catheters Companies - Pipeline Products by Stage of Development 20
  • Table 8: Cardiac Catheters - Pipeline Products by Stage of Development 22
  • Table 9: 3DT Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 10: Sizing Valvuloplasty Conductance Balloon Catheter - Product Status 24
  • Table 11: Sizing Valvuloplasty Conductance Balloon Catheter - Product Description 24
  • Table 12: Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 13: Ultrasonic Catheter - Cardiac Catheterization - Product Status 25
  • Table 14: Ultrasonic Catheter - Cardiac Catheterization - Product Description 25
  • Table 15: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 16: Coronary Angio Catheter - Product Status 26
  • Table 17: Coronary Angio Catheter - Product Description 26
  • Table 18: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 19: Specialty Coronary Catheter - Product Status 27
  • Table 20: Specialty Coronary Catheter - Product Description 27
  • Table 21: Balch Hill Medical Group Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 22: PrecisionThread - Product Status 28
  • Table 23: PrecisionThread - Product Description 28
  • Table 24: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 25: Crossing Catheter - Product Status 29
  • Table 26: Crossing Catheter - Product Description 29
  • Table 27: Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 28: Viper Catheter - Product Status 30
  • Table 29: Viper Catheter - Product Description 30
  • Table 30: Cardiac Output Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 31: Micro-Loop Catheter - Product Status 31
  • Table 32: Micro-Loop Catheter - Product Description 31
  • Table 33: Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 34: Diamondback 360 Coronary Orbital Atherectomy System - Product Status 32
  • Table 35: Diamondback 360 Coronary Orbital Atherectomy System - Product Description 33
  • Table 36: Cardiovascular Systems Inc - Ongoing Clinical Trials Overview 34
  • Table 37: Diamondback 360 Coronary Orbital Atherectomy System - Comparison of Orbital Versus Rotational Atherectomy Effects on Coronary Microcirculation in Percutaneous Coronary Intervention (PCI) 35
  • Table 38: Diamondback 360 Coronary Orbital Atherectomy System - Evaluation of Treatment Strategies for Severe CalcIfic Coronary Arteries: Orbital Atherectomy versus Conventional Angioplasty Technique Prior to Implantation of Drug-eluting Stents: The ECLIPSE Trial 35
  • Table 39: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 40: NOGA Guided Myostar Injection Catheter - Product Status 36
  • Table 41: NOGA Guided Myostar Injection Catheter - Product Description 36
  • Table 42: Cordis Corp - Ongoing Clinical Trials Overview 37
  • Table 43: NOGA Guided Myostar Injection Catheter - A Phase I, Open-label Study of the Effects of Percutaneous Administration of an Extracellular Matrix Hydrogel, VentriGel, Following Myocardial Infarction 38
  • Table 44: NOGA Guided Myostar Injection Catheter - A Phase I/II, Randomized, Placebo-controlled Study of the Safety and Efficacy of Transendocardial Injection of Autologous Human Cells (Mesenchymal or the Combination of MSC and Cardiac Stem Cells) in Patients with Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction 38
  • Table 45: CorNova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 46: FiberHalo SRM Post-Dilation Angioplasty Catheter - Product Status 39
  • Table 47: FiberHalo SRM Post-Dilation Angioplasty Catheter - Product Description 39
  • Table 48: FiberHalo SRM Pre-Dilation Angioplasty Catheter - Product Status 40
  • Table 49: FiberHalo SRM Pre-Dilation Angioplasty Catheter - Product Description 40
  • Table 50: FiberHalo SRM Stent Delivery Catheter - Product Status 40
  • Table 51: FiberHalo SRM Stent Delivery Catheter - Product Description 41
  • Table 52: Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 53: Multi-Steerable Catheter - Product Status 42
  • Table 54: Multi-Steerable Catheter - Product Description 42
  • Table 55: Deliverance Ltd. Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 56: Laparoscopic Braided Sealer And Filler Catheter - Product Status 43
  • Table 57: Laparoscopic Braided Sealer And Filler Catheter - Product Description 43
  • Table 58: EndoCross Ltd. Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 59: ENABLER-C Catheter System - Product Status 44
  • Table 60: ENABLER-C Catheter System - Product Description 44
  • Table 61: EndoCross Ltd. - Ongoing Clinical Trials Overview 45
  • Table 62: ENABLER-C Catheter System - The ENABLER 3C Study is Investigating the Safety and Efficacy of the ENABLER-C Catheter System in Facilitating Guidewire Advancement Through Chronic Total Occlusions in the Coronary Arteries 46
  • Table 63: EP Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 64: Laser Based Thermodilution Catheter - Product Status 47
  • Table 65: Laser Based Thermodilution Catheter - Product Description 47
  • Table 66: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 67: MRI Catheter - Product Status 48
  • Table 68: MRI Catheter - Product Description 49
  • Table 69: Hadasit Medical Research Services and Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 70: Double Lumen PCI Guiding Catheter - Product Status 50
  • Table 71: Double Lumen PCI Guiding Catheter - Product Description 50
  • Table 72: Harvard University Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 73: Motion Compensated Catheter System - Product Status 51
  • Table 74: Motion Compensated Catheter System - Product Description 51
  • Table 75: iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 76: Navitian Micro Catheter - Product Status 52
  • Table 77: Navitian Micro Catheter - Product Description 52
  • Table 78: Sergeant Support Catheter - Product Status 53
  • Table 79: Sergeant Support Catheter - Product Description 53
  • Table 80: MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 81: MaRVis Catheter - Product Status 54
  • Table 82: MaRVis Catheter - Product Description 54
  • Table 83: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 84: Acoustic Catheter - Product Status 55
  • Table 85: Acoustic Catheter - Product Description 55
  • Table 86: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 87: Aortic Valve Guide Catheter - Product Status 56
  • Table 88: Aortic Valve Guide Catheter - Product Description 56
  • Table 89: Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 90: Cardiac/Carotid Aspirating Balloon Catheter - Product Status 57
  • Table 91: Cardiac/Carotid Aspirating Balloon Catheter - Product Description 57
  • Table 92: Ostial Stent Placement Catheter - Product Status 58
  • Table 93: Ostial Stent Placement Catheter - Product Description 58
  • Table 94: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 95: Low Profile FFR Micro-catheter - Product Status 59
  • Table 96: Low Profile FFR Micro-catheter - Product Description 59
  • Table 97: Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 98: Crossing Support Guide Catheter - Product Status 60
  • Table 99: Crossing Support Guide Catheter - Product Description 60
  • Table 100: Lamsano - Product Status 61
  • Table 101: Lamsano - Product Description 61
  • Table 102: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 103: Catheter - Coronary Ischemia - Product Status 62
  • Table 104: Catheter - Coronary Ischemia - Product Description 62
  • Table 105: Intramyocardial Injection Catheter - Product Status 63
  • Table 106: Intramyocardial Injection Catheter - Product Description 63
  • Table 107: Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 108: Ostial Flare - Product Status 64
  • Table 109: Ostial Flare - Product Description 64
  • Table 110: Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 111: NesStent's catheter - Product Status 65
  • Table 112: NesStent's catheter - Product Description 65
  • Table 113: NeuroInterventional Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 114: Catheter - Carotid Stenting - Product Status 66
  • Table 115: Catheter - Carotid Stenting - Product Description 66
  • Table 116: DVT Intervention System - Product Status 67
  • Table 117: DVT Intervention System - Product Description 67
  • Table 118: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 119: Micro Catheter - Product Status 68
  • Table 120: Micro Catheter - Product Description 68
  • Table 121: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 122: Triple Balloon Occlusion/ Infusion Catheter - Product Status 69
  • Table 123: Triple Balloon Occlusion/ Infusion Catheter - Product Description 69
  • Table 124: Ohio State University Wexner Medical Center Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 125: Cardiovascular Catheter - Congestive Heart Failure - Product Status 70
  • Table 126: Cardiovascular Catheter - Congestive Heart Failure - Product Description 70
  • Table 127: Ohio State University Wexner Medical Center - Ongoing Clinical Trials Overview 71
  • Table 128: Cardiovascular Catheter - Congestive Heart Failure - Safety and Feasibility of Cardiovascular Catheter in Treatment of Patients with Congestive Heart Failure 72
  • Table 129: Perseus Biomed Ltd. Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 130: Intravascular Catheter - Chronic Disease - Product Status 73
  • Table 131: Intravascular Catheter - Chronic Disease - Product Description 73
  • Table 132: Pi-Cardia Ltd Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 133: LeafLex - Product Status 74
  • Table 134: LeafLex - Product Description 74
  • Table 135: Second Generation Leaflex Performer Catheter - Product Status 75
  • Table 136: Second Generation Leaflex Performer Catheter - Product Description 75
  • Table 137: QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 138: Biodegradable Catheter - Product Status 76
  • Table 139: Biodegradable Catheter - Product Description 76
  • Table 140: Revamp Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 141: Doraya Catheter - Product Status 77
  • Table 142: Doraya Catheter - Product Description 77
  • Table 143: Revamp Medical Ltd - Ongoing Clinical Trials Overview 78
  • Table 144: Doraya Catheter - First in Human Study of the Doraya Catheter for the Treatment of AHF Patients 79
  • Table 145: Rhythm Solutions Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 146: Cardiovascular Catheter - Gene Therapy - Product Status 80
  • Table 147: Cardiovascular Catheter - Gene Therapy - Product Description 80
  • Table 148: Sonix Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 149: Percutaneous Ultrasonic Drug Delivery System - Product Status 81
  • Table 150: Percutaneous Ultrasonic Drug Delivery System - Product Description 81
  • Table 151: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 152: TrapLiner Catheter - Product Status 82
  • Table 153: TrapLiner Catheter - Product Description 82
  • Table 154: Therix Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 155: Cardiac Diagnostic Catheter - Product Status 83
  • Table 156: Cardiac Diagnostic Catheter - Product Description 83
  • Table 157: Topspin Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 158: IntraVascular MRI catheter - Product Status 84
  • Table 159: IntraVascular MRI catheter - Product Description 84
  • Table 160: TransCardiac Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 161: EndoCardiac Navigator - Product Status 85
  • Table 162: EndoCardiac Navigator - Product Description 85
  • Table 163: U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 164: MyoCath - Product Status 86
  • Table 165: MyoCath - Product Description 86
  • Table 166: MyoCath II - Product Status 87
  • Table 167: MyoCath II - Product Description 87
  • Table 168: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 169: Peripheral Venous Catheter/Cannula - Product Status 88
  • Table 170: Peripheral Venous Catheter/Cannula - Product Description 88
  • Table 171: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 89
  • Table 172: Cardiac Catheter - Product Status 89
  • Table 173: Cardiac Catheter - Product Description 89
  • Table 174: Delivery Catheter - Product Status 90
  • Table 175: Delivery Catheter - Product Description 90
  • Table 176: University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 91
  • Table 177: Pre-Hydrate Catheter - Product Status 91
  • Table 178: Pre-Hydrate Catheter - Product Description 91
  • Table 179: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 92
  • Table 180: Integrated Dual Lumen Catheter - Product Status 92
  • Table 181: Integrated Dual Lumen Catheter - Product Description 92
  • Table 182: University of Montreal Pipeline Products & Ongoing Clinical Trials Overview 93
  • Table 183: Multifunction Catheter - Product Status 93
  • Table 184: Multifunction Catheter - Product Description 93
  • Table 185: Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
  • Table 186: Accura - Product Status 94
  • Table 187: Accura - Product Description 94
  • Table 188: Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 95
  • Table 189: Forward Looking ICE - Product Status 95
  • Table 190: Forward Looking ICE - Product Description 95
  • Table 191: Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 96
  • Table 192: IRIS Transseptal Catheter - Product Status 96
  • Table 193: IRIS Transseptal Catheter - Product Description 96
  • Table 194: Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview 97
  • Table 195: Zone Isolation and Bypass System - Product Status 97
  • Table 196: Zone Isolation and Bypass System - Product Description 97
  • Table 197: Glossary 295

List of Figures

1.2 List of Figures

  • Figure 1: Cardiac Catheters - Pipeline Products by Stage of Development 14
  • Figure 2: Cardiac Catheters - Pipeline Products by Segment 15
  • Figure 3: Cardiac Catheters - Pipeline Products by Territory 16
  • Figure 4: Cardiac Catheters - Pipeline Products by Regulatory Path 17
  • Figure 5: Cardiac Catheters - Pipeline Products by Estimated Approval Date 18
  • Figure 6: Cardiac Catheters - Ongoing Clinical Trials 19
Back to Top